Related references
Note: Only part of the references are listed.Group I Metabotropic Glutamate Receptor Signalling and its Implication in Neurological Disease
Fabiola M. Ribeiro et al.
CNS & Neurological Disorders-Drug Targets (2012)
15-Deoxy-Δ12,14-prostaglandin J2 modulates manganese-induced activation of the NF-κB, Nrf2, and PI3K pathways in astrocytes
Eunsook Lee et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Astrocytes in the tempest of multiple sclerosis
Djordje Miljkovic et al.
FEBS LETTERS (2011)
Neuroinflammation Is Associated with Changes in Glial mGluR5 Expression and the Development of Neonatal Excitotoxic Lesions
Janelle Drouin-Ouellet et al.
GLIA (2011)
The contribution of activated astrocytes to Aβ production: Implications for Alzheimer's disease pathogenesis
Jie Zhao et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Methamphetamine toxicity and its implications during HIV-1 infection
Peter S. Silverstein et al.
JOURNAL OF NEUROVIROLOGY (2011)
Huntington's Disease and Group I Metabotropic Glutamate Receptors
Fabiola M. Ribeiro et al.
MOLECULAR NEUROBIOLOGY (2011)
Loss of Object Recognition Memory Produced by Extended Access to Methamphetamine Self-Administration is Reversed by Positive Allosteric Modulation of Metabotropic Glutamate Receptor 5
Carmela M. Reichel et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Novel Neuroinflammatory Targets in the Chronically Injured Spinal Cord
Ahdeah Pajoohesh-Ganji et al.
NEUROTHERAPEUTICS (2011)
HIV-1 gp120 Induces Expression of IL-6 through a Nuclear Factor-Kappa B-Dependent Mechanism: Suppression by gp120 Specific Small Interfering RNA
Ankit Shah et al.
PLOS ONE (2011)
Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin
Joana Goncalves et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2010)
Methamphetamine Causes Mitrochondrial Oxidative Damage in Human T Lymphocytes Leading to Functional Impairment
Raghava Potula et al.
JOURNAL OF IMMUNOLOGY (2010)
Metabotropic Glutamate Receptor-Mediated Cell Signaling Pathways Are Altered in a Mouse Model of Huntington's Disease
Fabiola M. Ribeiro et al.
JOURNAL OF NEUROSCIENCE (2010)
Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis
J. Kuhle et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells
Servio H. Ramirez et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Methamphetamine-Induced Early Increase of IL-6 and TNF-alpha mRNA Expression in the Mouse Brain
Joana Goncalves et al.
DRUG ADDICTION: RESEARCH FRONTIERS AND TREATMENT ADVANCES (2008)
A Role for mGluR5 Receptors in Intravenous Methamphetamine Self-Administration
Megan P. H. Osborne et al.
DRUG ADDICTION: RESEARCH FRONTIERS AND TREATMENT ADVANCES (2008)
Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis
Thomas S. Guillot et al.
JOURNAL OF NEUROCHEMISTRY (2008)
The Role of Oxidative Stress, Metabolic Compromise, and Inflammation in Neuronal Injury Produced by Amphetamine-Related Drugs of Abuse
Bryan K. Yamamoto et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2008)
Methamphetamine inhibits antigen processing, presentation, and phagocytosis
Zsolt Talloczy et al.
PLOS PATHOGENS (2008)
Chronic stress enhances methamphetamine-induced extracellular glutamate and excitotoxicity in the rat striatum
Despina A. Tata et al.
SYNAPSE (2008)
Involvement of oxidative stress-activated JNK signaling in the methamphetamine-induced cell death of human SH-SY5Y cells
Sheng-Fan Wang et al.
TOXICOLOGY (2008)
Interactions between methamphetamine and environmental stress: role of oxidative stress, glutamate and mitochondrial dysfunction
Despina A. Tata et al.
ADDICTION (2007)
High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus
John F. Bowyer et al.
SYNAPSE (2006)
Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse
Minoru Narita et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Blood-brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions
Yuri Persidsky et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2006)
Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity:: role of tumor necrosis factor-α
K Sriram et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors
WJ Xu et al.
SYNAPSE (2005)
Activation of the phosphoinositide 3-kinase-akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression
LF Hou et al.
JOURNAL OF NEUROSCIENCE (2004)
Neuroprotective action of MPEP, a selective mGluR5 antagonist, in methamphetamine-induced dopaminergic neurotoxicity is associated with a decrease in dopamine outflow and inhibition of hyperthermia in rats
K Golembiowska et al.
NEUROPHARMACOLOGY (2003)
Protection of dopaminergic neurons with a novel astrocyte modulating agent (R)-(-)-2-propyloctanoic acid (ONO-2506) in an MPTP-mouse model of Parkinson's disease
H Kato et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)
Methamphetamine activates DNA binding of specific redox-responsive transcription factors in mouse brain
YW Lee et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Methamphetamine induces AP-1 and NF-κB binding and transactivation in human brain endothelial cells
YW Lee et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2001)
Optic nerve head structure in glaucoma: astrocytes as mediators of axonal damage
JE Morgan
EYE (2000)
Share Paper
